Emerging targeted therapies for the treatment of non-small cell lung cancer

PR Halliday, CM Blakely, TG Bivona - Current oncology reports, 2019 - Springer
Abstract Purpose of Review Lung cancer remains the leading cause of cancer-related
mortality worldwide. Genetic and molecular profiling of non-small cell lung cancer (NSCLC) …
被引用次数：103 相关文章

Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer.

PR Halliday, CM Blakely, TG Bivona - Current Oncology Reports, 2019 - europepmc.org
Lung cancer remains the leading cause of cancer-related mortality worldwide. Genetic and
molecular profiling of non-small cell lung cancer (NSCLC) has led to the discovery of …

Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer

PR Halliday, CM Blakely… - Current oncology …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose of review Lung cancer remains the leading cause of cancer-related mortality
worldwide. Genetic and molecular profiling of non-small cell lung cancer (NSCLC) has led to …

Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer

PR Halliday, CM Blakely, TG Bivona - Current Oncology Reports, 2019 - inis.iaea.org
The treatment of lung cancer is increasingly biomarker-driven, as patients are selected for
targeted agents based on the identification of genetic alterations amenable to inhibition. Our …

Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer

PR Halliday, CM Blakely… - Current Oncology …, 2019 - search.proquest.com
The treatment of lung cancer is increasingly biomarker-driven, as patients are selected for
targeted agents based on the identification of genetic alterations amenable to inhibition. Our …